Studies with radiolabelled serum amyloid P component provide evidence for turnover and regression of amyloid deposits in vivo.

1. Quantitative scintigraphic and turnover studies, utilizing the specific binding affinity of serum amyloid P component for amyloid fibrils, have been developed as a tool for evaluating amyloid deposits in vivo. 2. Serial studies in over 300 patients have shown characteristic, diagnostic tissue distributions of amyloid in different types of amyloidosis. There is generally a poor correlation between quantity of amyloid and associated organ dysfunction. 3. Contrary to previous expectations, regression of amyloid has been demonstrated systematically for the first time: AA, AL and variant transthyretin-associated amyloid deposits often regress rapidly, and sometimes completely, if the supply of fibril protein precursors is substantially reduced.
AuthorsP N Hawkins
JournalClinical science (London, England : 1979) (Clin Sci (Lond)) Vol. 87 Issue 3 Pg. 289-95 (Sep 1994) ISSN: 0143-5221 [Print] ENGLAND
PMID7955904 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Review)
Chemical References
  • Amyloid
  • Iodine Radioisotopes
  • Serum Amyloid P-Component
  • Amyloid (metabolism)
  • Amyloidosis (metabolism, radionuclide imaging)
  • Animals
  • Humans
  • Iodine Radioisotopes
  • Serum Amyloid P-Component (pharmacokinetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: